CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
GORE® TAG® Thoracic Branch Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02021812
NCT02021812N/ACompleted
CompareCT.gov

Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms

W.L.Gore & Associates·interventional·Posted Dec 27, 2013·Updated Sep 9, 2022

In Brief

A clinical study evaluating GORE® TAG® Thoracic Branch Endoprosthesis for Aortic Aneurysm, Thoracic. Completed, enrolled 31 participants across 6 sites.

Detailed Summary

The purpose of this study is to assess the feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the proximal Descending Thoracic Aorta (DTA)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Thoracic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 27, 2013
Enrollment StartJan 1, 2014
Primary CompletionAug 1, 2016
Study CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 12.5 years ago

Interventions

GORE® TAG® Thoracic Branch Endoprosthesisdevice